GKWIM
ABBV icon

Gerber Kawasaki Wealth & Investment Management’s AbbVie ABBV Stock Holding History

Gerber Kawasaki Wealth & Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.18M Sell
4,706
-226
-5% -$48.6K 0.03% 160
2026
Q1 		$1.07M Buy
4,932
+206
+4% +$45.7K 0.03% 158
2025
Q4 		$1.08M Buy
4,726
+184
+4% +$41.9K 0.04% 157
2025
Q3 		$1.05M Buy
4,542
+183
+4% +$37.3K 0.04% 154
2025
Q2 		$809K Buy
4,359
+117
+3% +$21.7K 0.03% 161
2025
Q1 		$889K Buy
4,242
+112
+3% +$21.8K 0.04% 149
2024
Q4 		$734K Buy
4,130
+92
+2% +$16.9K 0.03% 155
2024
Q3 		$798K Sell
4,038
-547
-12% -$102K 0.04% 145
2024
Q2 		$786K Buy
4,585
+981
+27% +$163K 0.04% 142
2024
Q1 		$656K Buy
3,604
+61
+2% +$10.5K 0.04% 152
2023
Q4 		$549K Sell
3,543
-2,287
-39% -$333K 0.03% 155
2023
Q3 		$869K Buy
5,830
+658
+13% +$96.6K 0.06% 135
2023
Q2 		$697K Buy
5,172
+819
+19% +$120K 0.05% 144
2023
Q1 		$694K Sell
4,353
-455
-9% -$69.6K 0.05% 146
2022
Q4 		$777K Buy
4,808
+218
+5% +$33.4K 0.07% 140
2022
Q3 		$616K Sell
4,590
-1,209
-21% -$173K 0.06% 143
2022
Q2 		$888K Buy
5,799
+1,205
+26% +$184K 0.08% 121
2022
Q1 		$744K Sell
4,594
-539
-11% -$78.3K 0.06% 129
2021
Q4 		$695K Buy
5,133
+80
+2% +$9.45K 0.06% 139
2021
Q3 		$545K Buy
5,053
+2,244
+80% +$256K 0.07% 103
2021
Q2 		$316K Buy
2,809
+484
+21% +$54.5K 0.03% 184
2021
Q1 		$251K Buy
+2,325
New +$249K 0.03% 184
2018
Q2 		– Sell
-2,912
Closed -$275K – 106
2018
Q1 		$275K Buy
+2,912
New +$320K 0.09% 95
2017
Q3 		– Sell
-12,796
Closed -$919K – 108
2017
Q2 		$919K Hold
12,796
– – 0.35% 58
2017
Q1 		$831K Hold
12,796
– – 0.36% 55
2016
Q4 		$801K Buy
12,796
+1,000
+8% +$61K 0.42% 49
2016
Q3 		$743K Hold
11,796
– – 0.43% 47
2016
Q2 		$730K Sell
11,796
-400
-3% -$24.4K 0.46% 46
2016
Q1 		$696K Sell
12,196
-63
-0.5% -$3.51K 0.48% 43
2015
Q4 		$726K Buy
+12,259
New +$706K 0.49% 42

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Gerber Kawasaki Wealth & Investment Management's ABBV Position: Q2 2026 in Review

Gerber Kawasaki Wealth & Investment Management reduced its AbbVie (ABBV) stake by 4.6% in Q2 2026, selling an estimated $48.6K and leaving 4,706 shares worth $1.18M. The position accounts for 0.03% of the portfolio, ranked #160.

Gerber Kawasaki Wealth & Investment Management first reported a position in ABBV in Q4 2015 and has held it in 30 quarters since. 3,232 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Gerber Kawasaki Wealth & Investment Management held 4,706 shares of AbbVie worth $1.18M as of Q2 2026.
  • Gerber Kawasaki Wealth & Investment Management sold 226 AbbVie shares in Q2 2026, an estimated $48.6K.
  • AbbVie made up 0.03% of Gerber Kawasaki Wealth & Investment Management's portfolio in Q2 2026, its #160 holding.
  • Gerber Kawasaki Wealth & Investment Management first reported a position in AbbVie in Q4 2015 and has held it in 30 quarters since.
  • 3,232 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Gerber Kawasaki Wealth & Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.